ArticleFrontiers in oncology2021

Case Report: Significant Clinical Benefit From Pemetrexed-Based Therapy in ROS1- and ALK-rearranged Lung Cancer With Adenosquamous Histology.

Tejas Patil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.